CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial

Popmihajlov, Z., Sutherland, D. J., Horan, G. S., Ghosh, A., Lynch, D. A., Noble, P. W., Richeldi, L., Reiss, T. F., & Greenberg, S. (2022). CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial. BMJ Open Respiratory Research, 9(1), e001060. https://doi.org/10.1136/bmjresp-2021-001060
Authors:
Zoran Popmihajlov
Donna J Sutherland
Gerald S Horan
Atalanta Ghosh
David A Lynch
Paul W Noble
Luca Richeldi
Theodore F Reiss
Steven Greenberg
Affiliated Authors:
Steven Greenberg
Columbia Affiliation:
Subjects:
Idiopathic Pulmonary Fibrosis (MeSH)
Lung Diseases, Interstitial (MeSH)
Protein Kinase Inhibitors (MeSH)
Author Keywords:
interstitial fibrosis
elink
Publication Type:
Article
Unique ID:
10.1136/bmjresp-2021-001060
PMID:
35058236
DOI:
10.1136/bmjresp-2021-001060
Journal:
BMJ Open Respiratory Research
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: